Impact of HIV on Plasmacytoid Dendritic Cells
Author Information
Author(s): Meyers Jennifer Hartt, Justement J. Shawn, Hallahan Claire W., Blair Eric T., Sun Yongming A., O'Shea M. Angeline, Roby Gregg, Kottilil Shyam, Moir Susan, Kovacs Colin M., Chun Tae-Wook, Fauci Anthony S.
Primary Institution: National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)
Hypothesis
Can plasmacytoid dendritic cells (pDCs) suppress HIV replication and what mechanisms are involved in their depletion in HIV-infected individuals?
Conclusion
The study shows that pDCs from HIV-infected individuals can suppress HIV replication, particularly in those with low viral loads, but are also subject to HIV-mediated cell death.
Supporting Evidence
- Activated pDCs from HIV-infected individuals can suppress HIV replication in autologous CD4+ T cells.
- Unstimulated pDCs from low-viremic individuals showed greater HIV suppression compared to those from high-viremic individuals.
- HIV can induce apoptosis and necrosis in pDCs, contributing to their depletion in HIV-infected individuals.
- Distinct gene expression profiles were observed in pDCs from low-viremic versus high-viremic individuals.
Takeaway
This study found that special immune cells called plasmacytoid dendritic cells can help fight HIV, but HIV can also kill these cells, making it harder for the body to control the virus.
Methodology
The study involved isolating pDCs from HIV-infected individuals and testing their ability to suppress HIV replication in autologous CD4+ T cells through various assays.
Potential Biases
Potential biases may arise from the selection of participants and the specific assays used.
Limitations
The study primarily focuses on ex vivo conditions and may not fully represent in vivo dynamics.
Participant Demographics
The study included 45 HIV-infected individuals with varying levels of plasma viremia and CD4+ T cell counts.
Statistical Information
P-Value
p=0.03 and p=0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website